Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdita Food Regs Regulatory News (EFID)

  • There is currently no data for EFID

Edita's Board Resolution

4 Mar 2024 07:00

RNS Number : 3638F
Edita Food Industries S.A.E.
03 March 2024
 

 

Edita Food Industries - Summary of Resolutions of the Board of Directors Meeting of the company convened on Sunday dated 03/03/2024

 

Giza, 03/03/2024, Edita Food Industries S.A.E. ("the Company") announces that the Board of Directors Meeting of the Company convened on Sunday dated 03/03/2024 and unanimously resolved the following resolutions:

1) Approval of the minutes of the previous Board of Directors Meeting (No. 180) dated 05/11/2023.

 

2) Approval of the Company's balance sheet and profit and loss accounts and approved the Board of Directors' report for the Company's activities for the fiscal year ending on 31/12/2023 as well as the approval of the corporate governance annual report and the Auditor's report thereon to be submitted to the ordinary general assembly.

3) Approval of the Auditor's report on the standalone and consolidated financial statements for the fiscal year ending on 31/12/2023 to be submitted to the ordinary general assembly.

 

4) Approval of the Company's standalone and consolidated financial statements for the fiscal year ending on 31/12/2023 to be submitted to the ordinary general assembly.

 

5) Approval of the distribution of dividends for the fiscal year ending on 31/12/2023, to be submitted to the ordinary general meeting, which comprises of:

1. distributing cash dividends for the fiscal year ending on 31/12/2023 on the shareholders in the amount of EGP 300 Million, by way of a coupon of 0.429 EGP for each share, to be presented to the ordinary general meeting for its approval.

2. Allocating an amount of EGP 140,002,731.2 from the retained earnings according to the financial statements of 31/12/2023 to be distributed by way of free shares. This is Subject to the Ordinary General Assembly approval on the profit distribution proposed by the Board of Directors in relation to the allocation of an amount of EGP 140,002,731.2to be distributed as free shares. The distribution of said shares shall be subject to undertaking the necessary procedures and approvals in accordance with EGX listing rules.

 

 

 

 

6) Approval of calling for the Ordinary General Meeting to convene and delegating the Chairman of the company in determining the place and methodology of convening the meeting and amending the date of meeting, as the case may be, to consider the following agenda:

1. Approving the Board of Directors report on Company's activities for the fiscal year ending

31/12/2023, and approving the corporate governance annual report and the Auditor's report thereon;

2. Approving the auditor's report for the standalone and consolidated financial statements for the fiscal year ending 31/12/2023;

3. Approving the Company's standalone and consolidated financial statements for the fiscal year ending 31/12/2023;

4. Approving the proposed profit distribution, which comprises of a profit distribution for the fiscal year ending on 31/12/2023;

5. Discharging the members of the Board of Directors from their liabilities for the fiscal year ending 31/12/2023;

6. Electing the Board of Directors and specifying their capacities, and determining allowances and remuneration for the fiscal year ending 31/12/2024 and determining the signatory authorities and the spending limit of the Company;

7. Authorizing the Board of Directors in concluding related party contracts during the fiscal year ending 31/12/2024;

8. Approve the renewal of the Management Agreement with Eng. Hani Nabih Berzi;

9. Approve the related party agreements concluded by Edita Food Industries S.A.E Subsidiaries during the fiscal year ending 31/12/2023;

10. Authorizing the Board of Directors to grant donations during the fiscal year ending 31/12/2024, and approve the donations granted during the fiscal year ending 31/12/2023; and

11. Appointing the Company's auditor for the fiscal year ending 31/12/2024 and determining his remuneration.

 

 

7) The Board of Directors has been updated on the audit committee report.

 

8) The Board of Directors has been updated with the remuneration committee report.

 

-Ends

Contacts

Ms. Menna Shams El Din

Head of Investor Relations and Corporate Affairs

T: +202 3851 6464 | M: +20 100 1542428 |  menna.shamseldin@edita.com.eg

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMQKNBBPBKDQNK
Date   Source Headline
27th Aug 20258:36 amRNSEdita- EGM Invitation
20th Aug 20257:29 amRNSEdita Announcement on 2nd Tranche Distribution
11th Aug 20254:08 pmRNSEdita Board Resolutions dated 11 August 2025
11th Aug 20254:08 pmRNSEdita reports 2Q2025
30th Jul 20252:05 pmRNSEdita Announcement
23rd Jul 20257:00 amRNSEdita Board Resolutions dated 21 July 2025
21st Jul 20257:02 amRNSEdita Board Resolutions dated 20 July 2025
27th May 20257:00 amRNSEdita Board Resolutions dated 26 May 2025
27th May 20257:00 amRNS1st Quarter Results
20th May 20253:28 pmRNSEdita announcement the distribution of free shares
6th May 20257:00 amRNSEdita Board Resolutions dated 5 May 2025
23rd Apr 20256:28 pmRNSEdita IFRS Financial Statements 31-12 2024
16th Apr 20253:53 pmRNSEdita EGM Resolutions dated 2025
9th Apr 20253:24 pmRNSEdita - Announcement on Dividend Distribution
7th Apr 20257:00 amRNSEdita OGM Resolutions dated 6 April 2025
24th Mar 20257:00 amRNSEdita EGM Invitation Scheduled 16 April 2025
13th Mar 20257:09 amRNSEdita OGM Invitation dated 6 April 2025
13th Mar 20257:00 amRNSEdita Board Resolutions Dated March 13, 2025
10th Mar 20257:00 amRNSEdita Board Resolutions Dated 9 March 2025
10th Mar 20257:00 amRNSEdita reports FY2024
20th Jan 20257:00 amRNSEdita Board Resolutions dated 16 Jan 2025
20th Jan 20257:00 amRNSEdita - Iraq Partnership
25th Nov 20244:33 pmRNSEdita Report 3Q2024
25th Nov 20244:18 pmRNSEdita Board Resolutions 3Q2024 dated 25 Nov. 2024
11th Nov 20241:01 pmRNSDividend Announcement
11th Nov 20247:00 amRNSEdita signs toll manufacturing agreement withMIFAD
7th Nov 20249:06 amRNSEdita's Board Resolutions dated 6 November 2024
7th Nov 20248:59 amRNSEdita's OGM Resolutions
21st Oct 20249:25 amRNSEdita's OGM Invitation 6 November 2024
14th Oct 20242:51 pmRNSEdita's Board Resolutions dated 14 October 2024
13th Aug 20243:36 pmRNSEdita reports 2Q2024
13th Aug 20243:34 pmRNSEdita Board Resoluations dated 13 August 2024
30th Jul 20241:36 pmRNSEdita's Board Resolutions dated 30 July 2024
9th Jul 202411:20 amRNSResignation of Mr. Hassan Elkhatib
13th Jun 20248:39 amRNSEdita's Board Resolutions dated 12 June 24
23rd May 202412:48 pmRNSEdita Financial Statements-IFRS
20th May 20244:12 pmRNSEdita Board Resolution 1Q2024
20th May 20244:07 pmRNSEdita Reports 1Q2024
20th May 20247:00 amRNSEdita's board resolutions
13th May 20247:00 amRNSEdita signed a loan agreement
22nd Apr 202412:26 pmRNSEdita's IFRS financials-FY2023
4th Apr 20249:12 amRNSDividends Announcement
2nd Apr 20247:00 amRNSOGM Resolution
11th Mar 20248:52 amRNSNomination of OGM details
6th Mar 20247:00 amRNSEdita's OGM Invitation
4th Mar 20247:00 amRNSEdita's Board Resolution
4th Mar 20247:00 amRNSEdita FY2023 Results
21st Dec 202312:54 pmRNSEdita's Disclosure
27th Nov 20239:54 amRNSEGM minutes
13th Nov 20237:00 amRNSDistribution of dividends

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.